Thein SL - Search Results

1

Voxelotor treatment of a patient with sickle cell disease and very severe anemia.

Shet AS, Mendelsohn L, Harper J, Ostrowski D, Henry ER, Gwaabe E, Nichols J, Alayash AI, Eaton WA, Thein SL. Shet AS, et al. Among authors: thein sl. Am J Hematol. 2019 Apr;94(4):E88-E90. doi: 10.1002/ajh.25389. Epub 2019 Jan 8. Am J Hematol. 2019. PMID: 30592074 Free PMC article. No abstract available.

2

Hydroxyurea therapy lowers circulating DNA levels in sickle cell anemia.

Ulug P, Vasavda N, Kumar R, Keir L, Awogbade M, Cunningham J, Rees DC, Menzel S, Thein SL. Ulug P, et al. Among authors: thein sl. Am J Hematol. 2008 Sep;83(9):714-6. doi: 10.1002/ajh.21237. Am J Hematol. 2008. PMID: 18615556 Free article.

3

How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.

Gardner K, Hoppe C, Mijovic A, Thein SL. Gardner K, et al. Among authors: thein sl. Br J Haematol. 2015 Sep;170(6):745-56. doi: 10.1111/bjh.13494. Epub 2015 May 13. Br J Haematol. 2015. PMID: 25967919 Free article. Review.

4

Super-elevated LDH and thrombocytopenia are markers of a severe subtype of vaso-occlusive crisis in sickle cell disease.

Gardner K, Thein SL. Gardner K, et al. Among authors: thein sl. Am J Hematol. 2015 Oct;90(10):E206-7. doi: 10.1002/ajh.24126. Epub 2015 Sep 1. Am J Hematol. 2015. PMID: 26205137 Free article. No abstract available.

5

Reversible binding of hemoglobin to band 3 constitutes the molecular switch that mediates O2 regulation of erythrocyte properties.

Chu H, McKenna MM, Krump NA, Zheng S, Mendelsohn L, Thein SL, Garrett LJ, Bodine DM, Low PS. Chu H, et al. Among authors: thein sl. Blood. 2016 Dec 8;128(23):2708-2716. doi: 10.1182/blood-2016-01-692079. Epub 2016 Sep 29. Blood. 2016. PMID: 27688804 Free PMC article.

6

World Sickle Cell Day 2016 : A time for appraisal.

Thein MS, Thein SL. Thein MS, et al. Among authors: thein sl. Indian J Med Res. 2016 Jun;143(6):678-681. doi: 10.4103/0971-5916.191917. Indian J Med Res. 2016. PMID: 27748290 Free PMC article. No abstract available.

7

Sickle cell disease in the older adult.

Thein MS, Igbineweka NE, Thein SL. Thein MS, et al. Among authors: thein sl. Pathology. 2017 Jan;49(1):1-9. doi: 10.1016/j.pathol.2016.10.002. Epub 2016 Nov 30. Pathology. 2017. PMID: 27914684 Free PMC article. Review.

8

Therapeutic advances in sickle cell disease in the last decade.

Shet AS, Thein SL. Shet AS, et al. Among authors: thein sl. Indian J Med Res. 2017 Jun;145(6):708-712. doi: 10.4103/ijmr.IJMR_1153_17. Indian J Med Res. 2017. PMID: 29067969 Free PMC article. No abstract available.

9

Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease.

Thein SL. Thein SL. Adv Exp Med Biol. 2017;1013:27-57. doi: 10.1007/978-1-4939-7299-9_2. Adv Exp Med Biol. 2017. PMID: 29127676 Review.

10

Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant.

Darbari DS, Liljencrantz J, Ikechi A, Martin S, Roderick MC, Fitzhugh CD, Tisdale JF, Thein SL, Hsieh M. Darbari DS, et al. Among authors: thein sl. Br J Haematol. 2019 Feb;184(4):690-693. doi: 10.1111/bjh.15169. Epub 2018 Mar 12. Br J Haematol. 2019. PMID: 29527656 Free PMC article. Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters